VERTEX PHARMACEUTICALS INC / MA (VRTX) Operating cash flow 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$3.6BFY2025 · since FY2016: $236.1M → $3.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.6B | +837.2% |
| FY2024 | -$492.6M | -113.9% |
| FY2023 | $3.5B | -14.3% |
| FY2022 | $4.1B | +56.2% |
| FY2021 | $2.6B | -18.7% |
| FY2020 | $3.3B | +107.3% |
| FY2019 | $1.6B | +23.5% |
| FY2018 | $1.3B | +50.3% |
| FY2017 | $844.9M | +257.9% |
| FY2016 | $236.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice